🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I am looking for a postdoc (two years) with a background in sensorimotor control interested in doing research at the intersection of sensorimotor control and neurophysiology. If interested, please get in touch. RTs appreciated.

“We hacked your iCloud and will post all your pictures unless you send us $5000” Um please chill out, those are all articles I swear I’m going to read some day

Happy to announce CSH will be starting our own social media service! WatsonWatsoff will provide free verification for all faculty (with beards). Everyone else will need a new Cell/Sci/Nature paper a month to keep their verification.

This work was an immensely fun experience and what propelled me towards cellular immunotherapies for GBM! Special thanks to Kat Mueller, PhD for the free inspiration

Data from our 2nd CART GBM trial @PennMedEVDCSO Penn Medicine - Abramson Cancer Center Penn Neurosurgery is out in preprint form as we hope to continue to define better cell therapy and I-O combinations for #Glioblastoma

Lucky for everyone I am still at my poster until 5 today! Come say hi in section 35, number 18 ! #AACR2023

tell ur mom i luv her, thx

Excited to share our early phase 1 results for bivalent #CARTcells in recurrent #glioblastoma. Now online Nature Medicine. Awesome team effort! Penn Medicine Penn Medicine - Abramson Cancer Center Penn Neurosurgery DrORourke nature.com/articles/s4159…

Early results from a #glioblastoma clinical trial show that a “dual-target” #CART cell therapy approach appears to shrink brain tumors and may be a promising step toward cell therapy for solid tumors. Penn Medicine - Abramson Cancer Center Penn Neurosurgery DrORourke Nature Medicine spr.ly/6019k3Tqh

Check out early responses from our ongoing trial on dual targeting CARs for EGFR AND IL13Ra2 for GBM out in Nature Medicine today 😎

Pre-PhD: I'm not that clever Post-PhD: I have a sophisticated grasp of precisely how stupid I am in multiple fields

If you’re feeling down about the state of scientific collaboration today, get inspired by the backstory of the incredible new paper from Kat Mueller, PhD and Evan Weber out in nature now!!!

So excited to share this study looking at the dynamic interplay between GBM and CAR T cells during treatment using organoids and single cell multi-omics! Hopefully this moves us toward a better understanding of #immunotherapy in #GBM. Huge thanks to Song and Ming Labs DrORourke!

Also, a big shout out to Meghan Logun Yusha Sun Xin Wang Stephen Bagley for their extraordinary work using GBM organoids as high-fidelity real-time models for CAR T cell therapy testing in parallel with a clinical trial biorxiv.org/content/10.110…

Want to avoid doomscrolling election coverage for 30 mins this morning?

Fortunately, the academic job market has prepared me for crushing disappointment

Patient-derived glioblastoma organoids as real-time avatars for assess... sciencedirect.com/science/articl… Happy to report our work using #GBM organoids to predict #CART response in #glioblastoma Penn Medicine - Abramson Cancer Center

Our recent work on the use of glioblastoma organoids (GBOs) to assess CAR-T clinical trial responses in real time together with Meghan Logun Xin Wang Stephen Bagley Song and Ming Labs DrORourke is now online Cell Stem Cell!

For the first time, Penn Medicine researchers grew #glioblastoma organoids in the lab that accurately mirrored what was happening in patients' brains as they were treated with #CARTcelltherapy. Read more about the research here: spr.ly/6014QRSnw

Now online in Cell Stem Cell, our researchers used #glioblastoma organoids to assess CAR-T clinical trial responses in real time. DrORourke Stephen Bagley Meghan Logun Yusha Sun Xin Wang Song and Ming Labs MacLean Nasrallah Daniel Zhang Emily Pai, MD PhD ➡️ spr.ly/6015Quxh9